INDP
Indaptus Therapeutics, Inc.
There isn't enough reported data to score INDP yet.
INDP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
INDP's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
INDP PE Valuation
INDP has no meaningful PE right now: it lost money over the past year.
INDP Forward outlook
There aren't enough analyst estimates for INDP to show an outlook.
INDP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$30.22 | +$14.86 |
| Q3 2025 | -$31.39 | +$16.21 |
| Q2 2025 | -$37.37 | +$14.43 |
| Q1 2025 | -$41.44 | +$8.12 |
| Q4 2024 | -$45.08 | +$6.16 |
| Q3 2024 | -$47.60 | +$3.15 |
| Q2 2024 | -$51.80 | -$2.45 |
| Q1 2024 | -$49.56 | +$1.75 |
INDP is still losing money, but less than at its worst: $30.22 per share over the past year, against $51.80 at its worst in mid-2024.
INDP Quarterly Revenue
INDP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.9M | +$2.1M |
| Q1 2026 | -$7M | -$2M |
| Q4 2025 | -$3.2M | +$205.2K |
| Q3 2025 | -$2.6M | -$54.4K |
| Q2 2025 | -$4M | -$1.5M |
| Q1 2025 | -$5M | -$1.1M |
| Q4 2024 | -$3.4M | -$793.8K |
| Q3 2024 | -$2.5M | +$1.2M |
INDP has burned cash in almost every quarter: −$15M over the past year, against −$15M the year before.
INDP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +73% | +422K shares |
| 1 year | +227% | +692K shares |
| 3 years | +238% | +702K shares |
INDP has 997,038 diluted shares, up 227% from a year ago.
INDP Net Leverage
INDP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
INDP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.1 | Neutral |
| Stochastic | 68.7 | Neutral |
INDP's weekly RSI is 54 (neutral) and its Stochastic is 69 (neutral).
INDP PE vs Healthcare Sector
INDP has no meaningful PE right now: it lost money over the past year.
INDP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 4.7% above |
| 20 week MA | $2.42 | 30% above |
| 50 week MA | $2.41 | 31% above |
| 100 week MA | $7.36 | 57% below |
| 200 week MA | $31.2 | 90% below |
INDP has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 90% below its 200-week average.
INDP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,052.8 | $439.0 | -58% |
| 2021 | $439.0 | $169.4 | -61% |
| 2022 | $169.4 | $42.6 | -75% |
| 2023 | $42.6 | $49.3 | +16% |
| 2024 | $49.3 | $23.4 | -52% |
| 2025 | $23.4 | $2.55 | -89% |
| 2026 YTD | $2.55 | $3.15 | +24% |
INDP has finished lower in five of the last six years. It's up 24% so far in 2026.